title: Tadalafil for erectile dysfunction prevention after radiotherapy for prostate cancer.
authors.affiliation: Division of Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
authors.forename: Fabio
authors.initials: F
authors.lastname: Castiglione
authors.affiliation: Division of Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Montorsi
authors.affiliation: Division of Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
authors.forename: Alberto
authors.initials: A
authors.lastname: Briganti
mesh_terms: D002243:Carbolines / Q000627:therapeutic use*; D007172:Erectile Dysfunction / Q000517:prevention & control*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011832:Radiation Injuries / Q000517:prevention & control*; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D002243:Carbolines; D014665:Vasodilator Agents